Mirae Asset Global ETFs Holdings
ENTA icon

Mirae Asset Global ETFs Holdings’s Enanta Pharmaceuticals ENTA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$191K Buy
13,067
+93
+0.7% +$1.25K ﹤0.01% 2504
2026
Q1 		$164K Buy
12,974
+306
+2% +$4.1K ﹤0.01% 2453
2025
Q4 		$200K Buy
12,668
+2,962
+31% +$37.6K ﹤0.01% 2350
2025
Q3 		$116K Sell
9,706
-1,771
-15% -$14.2K ﹤0.01% 2596
2025
Q2 		$86.8K Sell
11,477
-546
-5% -$3.28K ﹤0.01% 2679
2025
Q1 		$66.4K Buy
12,023
+552
+5% +$3.41K ﹤0.01% 2782
2024
Q4 		$66K Buy
11,471
+540
+5% +$5.18K ﹤0.01% 2847
2024
Q3 		$113K Buy
10,931
+1,169
+12% +$15.3K ﹤0.01% 2658
2024
Q2 		$127K Buy
+9,762
New +$132K ﹤0.01% 2465

Other funds holding ENTA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Mirae Asset Global ETFs Holdings's ENTA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Enanta Pharmaceuticals (ENTA) stake by 0.72% in Q2 2026, buying an estimated $1.25K and bringing the position to 13,067 shares worth $191K. The position accounts for ﹤0.01% of the portfolio, ranked #2504.

Mirae Asset Global ETFs Holdings first reported a position in ENTA in Q2 2024 and has held it in 9 quarters since. The position peaked at $200K in Q4 2025. 123 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 13,067 shares of Enanta Pharmaceuticals worth $191K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 93 Enanta Pharmaceuticals shares in Q2 2026, an estimated $1.25K.
  • Enanta Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2504 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Enanta Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Enanta Pharmaceuticals position peaked at $200K in Q4 2025.
  • 123 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.